Pathology
Partner With Us
Advertisement
Conexiant chevron_right Pathology chevron_right CD68 CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma Study
From the Journals

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.